With 6 observations
Lupin announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried out at its Pithampur Unit -2 (Indore) facility. The inspection was carried out between 14 January and 25 January 2019. The inspection at Pithampur Unit-2 (Indore) closed with 6 observations. The Company is confident of addressing the observations satisfactorily.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)